Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended letrozole 7-day versus 10-day treatment in letrozole-resistant PCOS
IRCT20110908007513N19Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Relative frequency of clinical pregnancy. Started Jun 2024; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20110908007513N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110908007513N19.